Semaglutide is an injection for subcutaneous administration
[2][9] The hashtag #GLP1Hack is one example of how consumers frame this practice as a clever workaround for high costs and side effects
Wegovy belongs to a class of drugs called GLP-1 receptor agonists, which imitates the natural hormone glucagon-like peptide-1 (GLP-1) to help control appetite, blood sugar, and metabolism
Tchang says, Errors in microdosing could result in overdosing, where you might be exposed to much higher doses than intended. Obesity medicine experts emphasize that any use of lower-than-approved doses should only occur under close medical supervision and with individualized guidance
Most insurance providers require prior authorization in order to consider covering weight loss medications
Moreover, the use of semaglutide has been related to the increased risk of cholelithiasis (65)